The COVID-19 pandemic highlighted the need for remote, but reliable hearing tests. Previous studies used remote testing but did not directly compare results in the same listeners with standard lab testing. Digits-in-noise (DIN) is a reliable speech-in-noise test that can be self-administered remotely. This study investigated the predictive validity of a self-administered DIN test and a commonly used self-report, the speech, spatial, and qualities of hearing (SSQ-12), for lab-based, supervised DIN and audiometry. Speech reception thresholds (SRTs) of 34 adults (18-64 y/o), 16 normal-hearing (NH) and 18 hearing-impaired (HI), were measured at home (remote-DIN) and in the lab (lab-DIN). All DIN testing used English digits 0-9, binaurally presented as triplets in different speech-shaped noise maskers (broadband, low-pass filtered at 2, 4, 8 kHz). Audiometry was administered during lab testing. An SSQ-12 e-version was completed by participants at home. As expected, NH listeners had significantly higher SSQ scores, and remote- and lab-DIN SRTs than HI listeners. All test versions of DIN were significantly correlated with pure-tone-average (PTA), with the 2-kHz filtered test the best predictor, explaining 50% of variance in PTA. SSQ also significantly predicted PTA. Overall, DIN-SRTs were better predictors of audiograms than the SSQ. Remote-DIN correlated significantly with lab-DIN, and there was no significant mean difference between remote- and lab-DIN. Test-retest reliability was measured for broadband remote-DIN. High, significant intraclass correlation coefficients indicated strong internal consistency of the remote-DIN. This study shows that remote SSQ-12 and DIN are valid screening tools for capturing important aspects of auditory function.

D.W.S. and D.R.M. have a relationship with the hearX Group that includes equity, consulting, and potential royalties.

This study was supported by NIH grant R21DC016241 and by the Cincinnati Childrens Hospital Research Foundation.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of Cincinnati Children's Hospital Medical Center gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

The data that support the findings of this study are available on request from the corresponding author.